Dihydroartemisinin (DHA) inhibits myofibroblast differentiation through inducing ferroptosis mediated by ferritinophagy

Idiopathic pulmonary fibrosis (IPF) is caused by persistent micro-injuries and aberrant repair processes. Myofibroblast differentiation in lung is a key event for abnormal repair. Dihydroartemisinin(DHA), a well-known anti-malarial drug, have been shown to alleviate pulmonary fibrosis, but its mecha...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Ningning Yu, Nan Wang, Weiqun Zhang, Junyu Xue, Quan zhou, Fengai Hu, Xuelian Bai, Naiguo Liu
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Subjects:	Differentiation of myofibroblasts Ferritinophagy FTH1 NCOA4 Dihydroartemisinin(DHA) Pulmonary fibrosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024033073